J.-I. Hong et al.
Compound 9: Trifluoroacetic acid (0.26 mL) was slowly added to a solu-
tion of compound 8 (118 mg, 0.132 mmol) in CH2Cl2 (5 mL). After being
stirred at room temperature for 24 h, the solvent was removed in vacuo
and dissolved in CH2Cl2. The organic phase was washed with water and
dried over Na2SO4. The reaction mixture was concentrated under re-
duced pressure. The resulting crude powder was crystallized from
CH2Cl2/hexane to provide the desired product as a white powder (70 mg,
ratio of IA/ID in the TTPensemble system shows more than
four times the enhancement compared with that of other nu-
cleotide ensemble systems. This ensemble system also dis-
played a relatively small energy transfer effect for ADP,
2ꢀ
AMP, and H PO4 (Figure S6 in the Supporting Informa-
2
tion). Therefore, TTPselectivity was achieved.
As a result, this phosphorescent ensemble system can be
used for the selective recognition of TTPdue to its intermo-
lecular ET efficiency.
89.4%). 1H NMR (300 MHz, [D3]acetonitrile): d=8.22 (d,
7.7 Hz, 4H), 7.78 (s, 3H), 7.64 (d, J(H,H)=8.2 Hz, 4H), 7.50 (t, J
8.2 Hz, 4H), 7.34 (t, J(H,H)=7.4 Hz, 4H), 4.10 (s, 2H), 3.20 (br, 4H)
J
ACHTREUNG
A
ACHTREUNG
AHCTREUNG
3.02 (m, 8H), 2.88 ppm (br, 4H); 13C NMR (125 MHz, [D6]acetone): d=
140.9, 140.8, 139.4, 127.7, 126.3, 124.9, 123.4, 120.2, 120.2, 110.1, 56.5,
48.6, 45.0, 42.7, 42.6 ppm; HRMS (FAB): m/z calcd for C39H41N6
[M+H]+: 593.3393; found: 593.3395.
Conclusion
Compound 1: Compound 9 (40 mg, 0.0612 mmol) in MeOH (1 mL) and
Zn(ClO4)2·6H2O in MeOH (1 mL) were combined and heated at reflux
for 1 h under nitrogen. Most of the solvent was removed in vacuo, and
the precipitated product was collected by filtration and dried in vacuo to
N
A phosphorescent TTPsensor was developed through a
donor–acceptor ensemble system using intermolecular ET.
Out of all nucleotides, TTPshows the best ET efficiency
yield the product as
1H NMR (300 MHz, CD3CN): d=8.24 (d, J
(H,H)=15.9 Hz, 1H), 7.75 (d, J(H,H)=11.5 Hz, 2H), 7.62 (t, J
8.2 Hz, 4H), 7.56–7.50 (m, 4H), 7.36 (t, J(H,H)=7.4 Hz, 4H), 4.21 (s,
a
white powder (22 mg, 48.4%). M.p. 2008C;
(H,H)=7.7 Hz, 4H), 8.01 (d,
(H,H)=
(>90%) due to the strong binding between Zn2+–cyclen
AHCTREUNG
J
A
A
ACHTREUNG
and the nucleobase. This system can be used for the selec-
tive sensing of TTPfrom the nucleotides on account of the
intermolecular ET.
AHCTREUNG
1H), 4.10 (s, 1H), 3.22–2.74 ppm (m, 16H); 13C NMR (125 MHz,
CD3CN): d=140.7, 139.3, 138.5, 128.8, 128.0, 126.4, 125.4, 123.4, 120.5,
109.9, 55.9, 49.2, 47.6, 45.0, 44.5, 43.7, 42.5, 42.3, 41.7 ppm; HRMS
(FAB): m/z calcd for C39H40N6ZnClO4 [M]+: 755.2091; found: 755.2072.
Compound 6: This compound was prepared according to the literature
procedure.[6]
Experimental Section
Compound 10: A mixture of 6 (100 mg, 0.141 mmol), bromoacetic acid
ethyl ester (94 mg, 0.563 mmol), and K2CO3 (29 mg, 0.210 mmol) was
heated at reflux in THF for 24 h. After cooling to room temperature, the
solvent was removed in vacuo and the residue was dissolved in CH2Cl2.
The organic phase was washed with water, washed with brine, and dried
over Na2SO4. The solvent was evaporated to give the crude product,
which was purified by column chromatography on silica gel with CH2Cl2/
methanol (100:1, v/v) as the eluent to provide the desired product as a
yellow powder (75 mg, 67%). 1H NMR (300 MHz, [D6]DMSO): d=8.59
Reagents: Buffer A solution contained 10 mm HEPES adjusted to pH 7.4
with NaOH. To make compounds 1 and 2 soluble in aqueous solvent, a
cosolvent system (H2O/DMSO=24:1) was used. The tetrasodium salt of
TTPand the di sodium salt of GTPwere purchased from Fluka. The diso-
A
dium salt of ATPwas purchased from Sigma. The disodium salt of CTP
was purchased from Aldrich. DIPEA, HOBt, and PyBOP were pur-
chased from Aldrich. Analytical thin-layer chromatography was per-
formed on Kieselgel 60F-254 plates obtained from Merck. Column chro-
matography was carried out on Merck silica gel 60 (70–230 mesh). All
solvents and reagents were commercially available and used without fur-
ther purification unless otherwise noted.
Instruments: 1H and 13C NMR spectra were recorded using an Advance
300 MHz Bruker spectrometer in CDCl3 and [D6]DMSO. UV/Vis spectra
were recorded on a Beckman DU 650 spectrophotometer. Mass spectra
were obtained using a MALDI-TOF mass spectrometer from Bruker or
(d, J
(H,H)=8.6 Hz, 1H), 7.67 (d, J
7.37–7.33 (m, 2H), 6.87–6.76 (m, 2H), 5.68 (dd, J
1H), 5.45 (dd, J(H,H)=8.6, 2.2 Hz, 1H), 4.99 (s, 2H), 4.15 (q, J
7.1 Hz, 2H), 1.18 ppm (t, J
(H,H)=7.1 Hz, 3H); 13C NMR (125 MHz,
ACHTREUNG
J
A
ACHTREUNG
AHCTREUNG
A
ACHTREUNG
AHCTREUNG
[D6]DMSO): d=170.2, 168.6, 163.5, 158.3, 153.9, 149.3, 148.5, 142.1,
139.8, 138.9, 130.4, 128.3, 126.4, 124.4, 124.0, 123.1, 114.1, 98.0, 66.2, 61.3,
14.4 ppm; MALDI-TOF: m/z calcd for C32H23F4IrN3O5 [M+H]+:
798.120; found: 798.448.
a
gas chromatography–mass spectrometer from JEOL. Fluorescence
spectra were recorded on a Jasco FP-7500 spectrophotometer.
Compound 7: A 1n aqueous solution of NaOH (1 mL) was added to a
solution of 10 (75 mg, 0.0941 mmol) in THF/H2O (1 mL/1 mL). After stir-
ring for 2 h at room temperature, the reaction mixture was acidified with
1n HCl. The solvent was removed in vacuo and dissolved in CH2Cl2. The
organic phase was washed with water and dried over Na2SO4. The solvent
was evaporated to give the desired product as a yellow powder (63 mg,
87%). 1H NMR (300 MHz, [D6]DMSO): d=13.3 (br, 1H), 8.59 (d, J-
Compound (4): This compound was prepared according to the literature
procedure.[6]
Compound (5): This compound was prepared according to the literature
procedure.[13]
Compound 8: (10-(3,5-Bis-carbazole-9-yl-benzyl)-1,4,7-tris(tert-butyloxy-
carbonyl)-1,4,7,10-tetraazacyclododecane): A mixture of 5mCP-Br (4)
(100 mg, 0.188 mmol), 3Boc–cyclen (5, 170 mg, 0.360 mmol), K2CO3
(62.4 mg, 0.451 mmol) was heated at reflux in acetonitrile for 24 h. After
cooling to room temperature, the solvent was removed in vacuo and dis-
solved in ethyl acetate. The organic phase was washed with water,
washed with brine, and dried over Na2SO4. The solvent was evaporated
to give the crude product, which was purified by column chromatography
on silica gel using ethyl acetate/hexane (1:3, v/v) as the eluent to provide
AHCTREUNG
A
ACHTREUNG
AHCTREUNG
AHCTREUNG
(125 MHz, [D6]DMSO): d=170.7, 170.0, 164.0, 158.5, 153.5, 149.4, 148.5,
142.2, 139.9, 138.7, 130.6, 128.3, 126.8, 124.5, 124.1, 123.4, 114.1, 98.0,
66.7 ppm; MALDI-TOF: calcd for C30H19F4IrN3O5 [M+H]+: 770.089;
found: 770.530.
the desired product as
(300 MHz, [D6]acetone): d=8.23 (d, J
7.61 (d, J(H,H)=8.2 Hz, 4H), 7.50 (t, J
a
white powder (132 mg, 78.5%). 1H NMR
(H,H)=7.7 Hz, 4H), 7.81 (s, 3H),
(H,H)=7.5 Hz, 4H), 7.31 (t, J-
Compound 14: A mixture of compound 7 (32 mg, 0.042 mmol), DIPEA
(11 mg, 0.085 mmol), PyBOP (21 mg, 0.041 mmol), and HOBt (3 mg,
0.040 mmol) was stirred in distilled CH2Cl2 (4 mL) for 1 h , followed by
slowly adding compound 3 in CH2Cl2 (1 mL). After stirring at room tem-
perature for 7 h, the mixture was diluted with CH2Cl2, and washed with
water and brine. The organic phase was dried over Na2SO4 and evaporat-
ed to dryness. The residue was purified by column chromatography on
AHCTREUNG
A
ACHTREUNG
A
4H), 1.47 (s, 9H), 1.28 ppm (s, 18H); 13C NMR (125 MHz, CDCl3): d=
156.3, 155.9, 141.3, 140.7, 139.2, 128.0, 126.3, 124.7, 123.6, 120.4, 120.3,
109.6, 79.7, 79.5, 56.8, 56.0, 55.2, 50.3, 47.8, 28.7, 28.4 ppm; MALDI-TOF:
m/z calcd for C54H66N6O6 [M+2H]+: 894.504; found: 894.417.
9618
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2008, 14, 9613 – 9619